Thermal ablation in non-small cell lung cancer: a review of treatment modalities and the evidence for combination with immune checkpoint inhibitors

Lung cancer is the leading cause of cancer death worldwide, with approximately 1.6 million cancer related deaths each year. Prognosis is best in patients with early stage disease, though even then five-year survival is only 55% in some groups. Median survival for advanced non-small cell lung cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Rangamuwa, Kanishka, Leong, Tracy, Weeden, Clare, Asselin-Labat, Marie-Liesse, Bozinovski, Steven, Christie, Michael, John, Tom, Antippa, Phillip, Irving, Louis, Steinfort, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Review Article on Lung Cancer and The Immune System
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264311/
https://www.ncbi.nlm.nih.gov/pubmed/34295682
http://dx.doi.org/10.21037/tlcr-20-1075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264311/
https://www.ncbi.nlm.nih.gov/pubmed/34295682
http://dx.doi.org/10.21037/tlcr-20-1075

Ejemplares similares